3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
9
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms
2
Lung Neoplasms
2
Liver Neoplasms
2
Glioma
2
Disease
2
Urinary Bladder Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Prostate Cancer, Hereditary, 7
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pathologic Complete Response
1
Oropharyngeal Neoplasms
1
Muscle Weakness
1
Lymphoma, Non-Hodgkin
1
Kidney Neoplasms
1
Inflammatory Breast Neoplasms
1
Hypoxia
1
Hodgkin Disease
1
Health Status Unknown
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Gemcitabine
3
Cyclophosphamide
3
romidepsin
2
pembrolizumab
2
duvelisib
2
Vincristine
2
Prednisone
2
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
2
Biopsy
2
Azacitidine
2
tazemetostat
1
spartalizumab
1
somatostatin, cyclic hexapeptide(Phe-Phe-Trp-Lys-Thr-Phe)-
1
sodium-iodide symporter
1
sintilimab
1
ruxolitinib
1
ixazomib
1
ivarmacitinib
1
fludarabine
1
etoposide phosphate
1
cemiplimab
1
cabiralizumab
1
belinostat
1
X-Rays
1
Watchful Waiting
1
Tomography, X-Ray Computed
1
Specimen Handling
1
Prednisolone
1
Photons
1
Oxaliplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Peripheral
×
Magnetic Resonance Imaging
×
90 days
×
Clear all
No trials found.